Back to Search
Start Over
Immobilization of Antibodies by Genetic Fusion to a Fungal Self-Assembling Adhesive Protein.
- Source :
-
Frontiers in molecular biosciences [Front Mol Biosci] 2021 Oct 19; Vol. 8, pp. 725697. Date of Electronic Publication: 2021 Oct 19 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Although antibody immobilization on solid surfaces is extensively used in several applications, including immunoassays, biosensors, and affinity chromatography, some issues are still challenging. Self-assembling protein layers can be used to coat easily different surfaces by direct deposition. A specific biofunctional layer can be formed using genetic engineering techniques to express fused proteins acting as self-immobilizing antibodies. In this study, fusion proteins combining the self-assembling adhesive properties of a fungal hydrophobin and the functionality of the single chain fragment variables (ScFvs) of two antibodies were produced. The chosen ScFvs are able to recognize marine toxins associated with algal blooms, saxitoxin, and domoic acid, which can bioaccumulate in shellfish and herbivorous fish causing food poisoning. ScFvs fused to hydrophobin Vmh2 from Pleurotus ostreatus were produced in Escherichia coli and recovered from the inclusion bodies. The two fusion proteins retained the functionality of both moieties, being able to adhere on magnetic beads and to recognize and bind the two neurotoxins, even with different performances. Our immobilization procedure is innovative and very easy to implement because it allows the direct functionalization of magnetic beads with ScFvs, without any surface modification. Two different detection principles, electrochemical and optical, were adopted, thus achieving a versatile platform suitable for different antigen detection methods. The sensitivity of the saxitoxin optical biosensor [limit of detection (LOD) 1.7 pg/ml] is comparable to the most sensitive saxitoxin immunosensors developed until now.<br />Competing Interests: Authors DIB and MBGG are employed by the company Metrohm DropSens. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Stanzione, Izquierdo-Bote, González García, Giardina and Piscitelli.)
Details
- Language :
- English
- ISSN :
- 2296-889X
- Volume :
- 8
- Database :
- MEDLINE
- Journal :
- Frontiers in molecular biosciences
- Publication Type :
- Academic Journal
- Accession number :
- 34738014
- Full Text :
- https://doi.org/10.3389/fmolb.2021.725697